Table 1 Liver NAD+ metabolome profile in rats.

From: Oral supplementation of nicotinamide riboside alters intestinal microbial composition in rats and mice, but not humans

 

Group mean (pmol/mg)

Main effect of diet

Main effect of treatment

 

CD-VE

CD-NR

HFD-VE

HFD-NR

% change from CD

95% CI

FDR adj. p-value

% change from VE

95% CI

FDR adj. p-value

ADPR

81.6

49.4

61.1

31

−29.6

(−68.9 to −7.3)

0.041

−43.5

(−83.1 to −19.9)

0.001

Me2PY/Me4PY

0.4

4.7

0.4

13.7

104.7

(8.1 to 287.6)

0.11

1447.1

(718.7 to 2823.6)

3.39E-07

MeNam

0

0

0

0

16.9

(−17.2 to 65)

0.464

−18.3

(−42.1 to 15.2)

0.381

NA

0

0.1

0

0.2

78.2

(−36.6 to 400.6)

0.392

90.5

(−32 to 433.3)

0.381

NAAD

0.2

0.9

0.3

0.8

39.2

(−19.5 to 140.7)

0.381

207.8

(78.4 to 431.2)

0.003

NAADP

0

0

0

0

−10.8

(−60.2 to 11.9)

0.517

−18.4

(−68.8 to 5.6)

0.31

NAD+

437.4

748.5

591.8

756.6

25.3

(−4.5 to 64.3)

0.259

45.8

(11.3 to 91.1)

0.044

NADP+

117.9

111.7

120.9

134.2

10.9

(−17.2 to 25.7)

0.452

3.7

(−26 to 19.7)

0.73

NAM

372.5

420.8

326.6

333.1

−16.8

(−56.1 to 4.2)

0.286

7.3

(−27.2 to 24.2)

0.573

NAMN

0.8

1.4

1.1

1.5

17.8

(−26.9 to 34.9)

0.392

51.1

(27.7 to 58.6)

0.044

NAR

0.8

1.1

0.7

0.9

−10.9

(−89.1 to 16.5)

0.573

36.5

(−19 to 50.3)

0.259

NMN

21.7

30.8

28.4

37

16.7

(−22.2 to 75.1)

0.517

43.8

(−4 to 115.4)

0.246

NR

8.4

11.7

7.7

10.2

−10.7

(−88.8 to 16.6)

0.573

34.8

(−22.2 to 49.2)

0.266

  1. NAD+-related metabolites were determined using target LC-MS in liver samples of rats. n = 6–8. Significant effects are highlighted in bold.
  2. CD control diet, HFD high-fat diet, NR nicotinamide riboside, VE vehicle.